This antibody does not cross-react with other tyrosine-phosphorylated ErbB family members.
本抗体不与其它酪氨酸位点被磷酸化的ErbB家族蛋白发生交叉反应。
Thus, we propose that MET amplification may promote drug resistance in other ERBB-driven cancers as well.
因此我们认为，MET的扩增可能增强其他一些由ERBB驱动的肿瘤的耐药性。
Thus, we propose that MET amplification may promote drug resistance in other ERBB-driven cancers as well.
因此我们认为，MET的扩增可能增强其他一些由ERBB驱动的肿瘤的耐药性。
应用推荐